CRISPR Screen Reveals How Ovarian Cancer Cells Resist Niraparib
A genome-wide CRISPR screen identifies UGCG-driven sphingolipid metabolism and protective autophagy as drivers of Niraparib resistance in ovarian cancer.
Tag: niraparib
HAT1 Emerges as a Driver of Glioblastoma Growth and Drug Sensitivity
A multi-omics study identifies the epigenetic regulator HAT1 as upregulated in glioblastoma, where its inhibition slows tumor growth and boosts ...
POPULAR NEWS
-
Resorbable Self-Locking Device for Canine Ovarian Pedicle Ligation Tested Across Four Veterinary Centres
-
Faster Bandwidth Exploration Brings Near-Real-Time Spatial-Temporal Kernel Density Visualizations
-
Marine heatwaves and typhoons reshaped Yellow Sea fungal communities, study finds
-
Mixed reality office reads bodies and moods to reshape virtual space